Navigation Links
Ingenuity Systems and TransMed Systems Integrate Software to Support Personalized Medicine Research

REDWOOD CITY, Calif., Oct. 19 /PRNewswire/ -- Ingenuity® Systems, the leading provider of information solutions for life science researchers, and TransMed Systems, a translational medicine software and services company, today announced an integration between IPA® software and XB Bio-Integration Suite (XB-BIS).  Researchers can now easily take pre-clinical and clinical data that is managed and statistically analyzed by XB-BIS, directly into IPA®, which is used by researchers to model, analyze, and explore various types of 'omics data to gain a deeper understanding of complex biological systems.

The software integration supports academic and commercial researchers who are studying how genes affect the way individuals respond to drug treatments. Joint customers will have a clear workflow to analyze pre-clinical and clinical data in the context of signaling and metabolic pathways, networks, and cellular processes available in IPA. This approach helps researchers move rapidly and confidently from hypothesis generation to validation experiments.

Nick Berens, CEO, TransMed Systems, said, "The integration between XB-BIS and IPA will enable physicians, clinicians and researchers to integrate the latest biological content, pathways and molecular networks into their translational medicine and research.  These enhanced capabilities will allow for more timely and informed treatment strategies and practices and improve personalized medicine."

Doug Bassett, Ph.D., CSO and CTO, Ingenuity Systems, stated, "Personalized medicine requires the ability to quickly translate large amounts of data into meaningful biological information.  We're very pleased that our partnership with TransMed will provide a streamlined platform from which researchers and clinicians will be able to collect and analyze data, link genotypes to phenotypes, identify potential biomarkers, generate powerful and informed hypotheses, and understand the molecular differences between patient populations for improved diagnostics and therapeutics."

About Ingenuity® Systems

Ingenuity Systems is a leading provider of information solutions and custom services for life science researchers, computational biologists and bioinformaticists, and life science industry suppliers. For more information visit:

About TransMed Systems

TransMed Systems, was founded as a next generation life science application and services company with headquarters in Cupertino, California. The focus of TransMed Systems is to provide leading edge software and service solutions expediting the complete life science work process from novel discovery to clinical application in an integrated environment. TransMed Systems markets its XB Bio-Integration Suite as a fully integrated biological and medical informatics solution that allows users to generate, refine, and validate causal hypotheses across disparate data sets. The purpose is to provide a complete solution in the area of translational biomedical research, whereby bench-side research can rapidly lead to discoveries that can be readily applied to bedside medicine.

SOURCE Ingenuity Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
2. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
3. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
4. BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB
5. Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health
6. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
7. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
8. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
9. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
10. PLC Systems Reports Fourth Quarter 2007 Results
11. PLC Systems Receives FDA Approval to Commence Pivotal Study Of RenalGuard(TM) In the U.S.
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
(Date:11/26/2015)... 2015 Research and Markets ( ) ... Care Market by Type (Dressings, Therapy Devices, Active Wound ... Out-Patient Facility), and Geography - Global Forecast to 2020" ... --> --> The purpose of this ... of the global advanced wound care market. It involves ...
(Date:11/26/2015)... , Nov. 26, 2015 Research and ... of the "2016 Future Horizons and Growth ... Market: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> --> ... of the Italian therapeutic drug monitoring market, including ...
Breaking Medicine Technology:
(Date:11/29/2015)... ... November 29, 2015 , ... Doctors who missed a ... to recognize the signs of mesothelioma and push for a diagnosis, especially in people ... website. Click here to read it now. , Researchers at Gifu ...
(Date:11/28/2015)... Diego, California (PRWEB) , ... November 28, 2015 ... ... medical image exchange technology and teleradiology services, has added Chris Hafey and Claude ... to exhibit at the Radiological Society of North America (RSNA) 2015 Annual Meeting ...
(Date:11/28/2015)... (PRWEB) , ... November 28, 2015 , ... Pixel Film ... customizable media panels to choose from, the possibilities are endless. Users have full control ... With the ProPanel: Pulse masking effects, users are sure to get heads to turn. ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article published ... that they are handling security in light of the recent terrorist attacks in Paris, ... attempt to stop an attack from reaching U.S. soil. Especially around special events that ...
(Date:11/27/2015)... ... 27, 2015 , ... "When I was traveling, I was ... N.J. "Many people catch diseases simply from sitting on such dirty toilet seats. ... from germs." , He developed the patent-pending QUDRATECS to eliminate the need to ...
Breaking Medicine News(10 mins):